药物警戒中不同对照选择的方法学综述
该综述探讨了基于自发报告系统的药物警戒研究中对照选择的问题,比较了活性对照、类排除对照和全数据参考集三种常用对照的优缺点,并指出目前尚不明确哪种对照最合适以及对照选择如何影响各种报告偏倚的方向性。
要点
- 自发报告系统的不比例分析中,对照选择直接影响药物-事件组合信号检测的结果。
- 活性对照、类排除对照和全数据参考集是信号检测研究常用的三种对照。
- 目前缺乏关于对照选择的一般性推荐,对照选择对偏倚方向性的影响尚不明确。
核心结论
- 基于自发报告系统的药物警戒研究使用不比例分析检测药物-事件组合,但对照选择尚无明确最佳方案。
- 不同对照选择(活性对照、类排除对照、全数据参考集)各有优缺点,且对照选择可能影响报告偏倚的方向性。
研究设计与样本
- 方法学综述,基于文献中的示例,回顾了信号检测研究中常用的对照选择方法。
主要发现
- 综述总结了活性对照、类排除对照和全数据参考集三种常用对照的优缺点。
- 目前尚不明确哪种对照最适合用于药物警戒,也不清楚对照选择如何影响各种报告偏倚的方向性。
局限性
- 尚无法就自发报告药物警戒挖掘中对照选择给出一般性推荐。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Pharmacovigilance studies based on spontaneous reporting systems use disproportionality analysis methods to identify drug-event combinations with higher-than-expected reporting. Enhanced reporting is deemed as a proxy for a detected signal and is used to generate drug safety hypotheses, which can then be tested in pharmacoepidemiologic studies or randomized controlled trials. Higher-than-expected reporting means that the reporting rate of a drug-event combination of interest is disproportionately higher than the rate in a specific comparator or reference set. Currently, it is unclear which comparator is the most appropriate for use in pharmacovigilance. Moreover, it is also unclear how the selection of a comparator may affect the directionality of the various reporting and other biases. This paper reviews commonly used comparators chosen for signal detection studies (active comparator, class-exclusion comparator, and full data reference set). We give an overview of the advantages and disadvantages of each method based on examples from the literature. We also touch upon the challenges related to the derivation of general recommendations for the selection of comparators when mining spontaneous reports for pharmacovigilance.
引用
- Gravel CA, Douros A. Considerations on the use of different comparators in pharmacovigilance: A methodological review. Br J Clin Pharmacol. 2023. PMID: 37226576. doi:10.1111/bcp.15802
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。